Ask AI

Text Module

Share

Program Content

Activities

  • GPRC5D BsAbs in RR MM
    GPRC5D-Directed Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: Clinical Evidence and Practice Implications
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 04, 2026

    Expires: March 03, 2027

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by an educational grant from Johnson & Johnson.

Johnson & Johnson